Clinical Trials

1 studies in Anemia

  1. Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia Rochester, MN View Summary

    Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia

    Location:

    Rochester, MN

    Trial status:

    Open for Enrollment

    Why is this study being done?

    The objective of this trial is to make an initial assessment for this new treatment regimen and to show it is equal or superior to the current standard practice. With this initial assessment be hope to gain information suggesting further study of this regimen or discontinuation of this regimen before exposing large numbers of patients to this new treatment option. We also will gain experience with this new regimen giving insights as to possible modifications in dosing and monitoring and selection of patients for future treatment in case of positive results. For this initial study we plan to enroll up to 24 patients.

    NCT ID:

    NCT00578266

    IRB Number:

    06-006216

    Who can I contact for additional information about this study?

    Rochester: Shakila Khan, MD 507-284-3442
                        


Contact us

Clinical studies questions

Cancer-related clinical studies questions

International patient clinical studies questions